Your browser doesn't support javascript.
loading
How Simian Virus 40 Hijacks the Intracellular Protein Trafficking Pathway to Its Own Benefit … and Ours.
Toscano, Miguel G; de Haan, Peter.
Afiliación
  • Toscano MG; Amarna Therapeutics SL, Sevilla, Spain.
  • de Haan P; Amarna Therapeutics BV, Leiden, Netherlands.
Front Immunol ; 9: 1160, 2018.
Article en En | MEDLINE | ID: mdl-29892296
Viruses efficiently transfer and express their genes in host cells and evolve to evade the host's defense responses. These properties render them highly attractive for use as gene delivery vectors in vaccines, gene, and immunotherapies. Among the viruses used as gene delivery vectors, the macaque polyomavirus Simian Virus 40 (SV40) is unique in its capacity to evade intracellular antiviral defense responses upon cell entry. We here describe the unique way by which SV40 particles deliver their genomes in the nucleus of permissive cells and how they prevent presentation of viral antigens to the host's immune system. The non-immunogenicity in its natural host is not only of benefit to the virus but also to us in developing effective SV40 vector-based treatments for today's major human diseases.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Terapia Genética / Técnicas de Transferencia de Gen / Virus 40 de los Simios / Vectores Genéticos Límite: Humans Idioma: En Revista: Front Immunol Año: 2018 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Terapia Genética / Técnicas de Transferencia de Gen / Virus 40 de los Simios / Vectores Genéticos Límite: Humans Idioma: En Revista: Front Immunol Año: 2018 Tipo del documento: Article País de afiliación: España
...